Pfizer is sued by Texas over COVID-19 vaccine claims
By Jonathan Stempel Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the
2023-12-01 04:54
Pfizer swings to loss as COVID product demand slump sparks charges
(Reuters) -Pfizer on Tuesday reported its first quarterly loss since 2019, as demand fell for its COVID products and it
2023-10-31 19:53
Pfizer, BioNtech say flu-COVID shot generates immune response
Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a
2023-10-26 19:26
US FDA approves Pfizer's maternal RSV vaccine to protect infants
By Patrick Wingrove and Bhanvi Satija The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial
2023-08-22 05:57
US FDA approves Pfizer's blood cancer therapy
(Reuters) -The U.S. Food and Drug Administration on Monday granted accelerated approval to Pfizer's therapy for treating patients with a
2023-08-15 02:19
GSK sues Pfizer in US for patent infringement over RSV vaccine
By Blake Brittain (Reuters) -British biopharmaceutical giant GSK sued Pfizer in a U.S. court on Wednesday, alleging that Pfizer's respiratory
2023-08-02 22:20
AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 billion
(Reuters) -AstraZeneca said on Friday its unit Alexion has agreed to buy U.S. drugmaker Pfizer's early-stage rare disease gene therapy
2023-07-28 14:25
EU health regulator backs Pfizer's RSV vaccine for infants, older adults
The European Union's health regulator on Friday backed authorization of Pfizer's vaccine for respiratory syncytial virus (RSV) for
2023-07-21 20:22
U.S. FDA approves Pfizer's COVID antiviral pill
The U.S. Food and Drug Administration on Thursday granted a full approval to Pfizer's Paxlovid, an oral antiviral
2023-05-25 22:26
U.S. FDA panel backs Pfizer's RSV vaccine for protecting infants
Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc's
2023-05-19 05:28
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'
By Michael Erman and Bhanvi Satija NEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate
2023-05-13 04:55